Our previous work showed that EZH2 is up-regulated in epithelial ovarian cancer (EOC) and that high EZH2 expression significantly correlates with poor cell differentiation, advanced FIGO (The International Federation of Gynecology and Obstetrics) stage and positive lymph node metastasis10. This evidence concerns the gene EZH2 and ovarian carcinoma.